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Sunday, March 1, 2009 93ainducesmembrane disruption to a similar extent as the full-length peptide. How-
ever, unlike the full-length IAPPpeptide, IAPP1-19 is conformationally stable in
a helical conformation when bound to the membrane. In vivo and in vitro mea-
surements of membrane disruption indicate the rat version of IAPP1-19, de-
spite differing from hIAPP1-19 by only by the single substitution of Arg18
for His18, is significantly less toxic than hIAPP1-19, in agreement with the
low toxicity of the full-length rat IAPP peptide. To investigate the origin of
this difference at the atomic level, we have solved the structures of the human
and rat IAPP1-19 peptides in DPC micelles, as well as the completely non-
toxic full-length rat and toxic full-length human peptide. While the structures
of rat and human IAPP1-19 are similar, the charge at residue 18 plays a key
role in controlling the toxicity of the peptide. At pH 7.3, the more toxic hI-
APP1-19 peptide is buried deeper within the micelle, while both the less toxic
rIAPP1-19 peptide and non-toxic full-length rIAPP peptide are located at the
surface of the micelle. Deprotonating H18 in hIAPP1-19 moves the peptide to
the surface of the micelle. This change in orientation is accompanied by a cor-
responding change in toxicity. At pH 6.0, the membrane disruption induced by
hIAPP1-19 is significantly decreased and resembles that of the less toxic
rIAPP1-19 peptide.
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The islet amyloid polypeptide (IAPP) is synthesized in the b-cells of the pan-
creas from its precursor, the proislet amyloid polypeptide (ProIAPP). ProIAPP
is co-processed in the secretory granules, and then co-secreted to the extracel-
lular matrix together with insulin. As indicated earlier, partially processed N-
terminal ProIAPP is able to interact with negatively charged moieties, like hep-
aran sulfate, which may lead to islet amyloid plaque formation. Amyloid pla-
ques have been found both extracellularly and intracellularly in type II diabetic
patients. Here, we studied the amyloidogenic propensity of native ProIAPP and
compared it with that of IAPP in the absence and presence of negatively
charged membranes. Our CD studies show that the secondary structure content
of ProIAPP and IAPP is predominantly unordered with small amounts of or-
dered secondary structure elements as confirmed by ATR-FTIR spectroscopy.
However, in the presence of anionic membranes, ProIAPP forms predomi-
nantly a-helices and loops that subsequently transform to intermolecular b-
sheet structures. For comparison, IAPP forms intermolecular b-sheets largely
via unordered and loop structures. The ATR-FTIR and fluorescence spectros-
copy studies performed also reveal that ProIAPP has a higher amyloidogenic
propensity in the presence of negatively charged membranes, but is still less
amyloidogenic than IAPP. AFM studies have also been carried out which
show that ProIAPP, at variance to IAPP, does not form long fibrils, but rather
protofilaments or short fibrils, only. Hence, both, the presence of a small
amount of unprocessed ProIAPP in b-cell secretion, or the interaction with neg-
atively charged surfaces, like negatively charged lipid bilayers, may initiate is-
let amyloid plaque formation.
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Previous work by others has shown that insulin inhibits the formation of fi-
brils from islet amyloid polypeptide. The mechanism for the inhibition is not
known. To address this issue, we are studying IAPP in the presence of lipid
membranes, with or without insulin. Circular dichroism spectra of IAPP
alone in phospholipid membranes show that it undergoes a structural rear-
rangement from a-helix to a b-sheet conformation. In the presence of
insulin, this transition is not observed, that is, IAPP remained a-helical.
To explain this, we are using other biophysical methods including solu-
tion-state NMR, electron microscopy, SDS-PAGE and limited proteolysis
monitored by mass spectrometry. Results from these studies will be pre-
sented and discussed in this poster.
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Sodium dodecyl sulfate has been proven as an amyloid-like misfolding agent
[1-3]. Our study comprises the biophysical characterization of human peptidesin the presence of submicellar and micellar concentrations of SDS. The prody-
norphin derived peptides (Big dynorphin, dynorphin A and dynorphin B) [4],
the amyloid b peptide [5], and the proinsulin derived C-peptide are our subject
of study. As determined by CD and FTIR spectroscopy, the peptide structural
transitions involve different secondary structures, such as random coil, b-sheet
and a-helix. By means of NMR, dynamic light scattering, native-PAGE or ThT
fluorescence, we have shown that all the peptides transit through a high molec-
ular weight aggregated state at submicellar detergent concentrations. Finally,
studies with model membranes with different charge composition have been
carried out to relate the structural characterization of these peptides to their pos-
sible role in the cell and their action mechanisms in pathology.
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Non-amyloidogenic beta peptides, p3 (Ab17-42) and Ab11-42, resulting from a-
secretase and BACE cleavage are often found in amyloid plaques. However,
the biophysical properties and functional role of these non-amyloidogenic pep-
tides are not understood. We present molecular dynamics (MD) simulations of
channels consisting of the U-shaped beta-strand-turn-beta-strand peptides us-
ing available NMR-based coordinates of p3 and Ab9-42. Our results show that
non-amyloidogenic p3 and Ab9-42 peptides form ion channel-like structures
with loosely attached subunits. These channels are dynamic and are made of
small peptide oligomers. The channels can conduct calcium and obtain shapes
and dimensions consistent with Atomic Force Microscopy (AFM) images. All
channels break into mobile subunits suggesting that membranes do not support
intact b-sheet channels. We shall further present results of modeling both PG-1
and k3-b2m channels, presenting a consistent general picture of toxic beta-sheet
based channels. Funded in part by DHHS #N01-CO-12400.
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Tau is the major protein component of the neurofibrillary tangles that charac-
terize a group of neurodegenerative diseases, including Alzheimers Disease.
The transformation of tau from its native state where it functions as a microtu-
bule-associated protein (MAP), to its pathological state as is found in patients
suffering from any of the various associated diseases, is not well understood.
Studies have shown that tau aggregation can be induced by anionic lipid vesi-
cles, and that detergent micelles can induce folding of the microtubule binding
domain of tau. Here we use fluorescence correlation spectroscopy (FCS) to
monitor the interaction of tau with synthetic lipid vesicles, in order to investi-
gate vesicle binding and aggregation. Studying several isoforms of tau, we find
that solution pH plays a strong role in such interactions.
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A peptide ubiquitous in human seminal fluid has been recently described that
dramatically enhances the infectivity of the HIV virus (3-5 orders of magnitude
by some measures). Previous studies have shown that this peptide, a fragment
of human Prostatic Acid Phosphatase (PAP248-286) referred to as SEVI (Semen-
derived Enhancer of Viral Infection), is amyloidogenic and the enhancement of
viral infectivity is dependent on the aggregation state of the peptide. To com-
plement these previous in vivo studies we have performed in vitro assays to in-
vestigate the physical mechanisms by which the PAP248-286 promotes the inter-
action with lipid bilayers. Our results indicate a strong interaction of freshly
dissolved PAP248-286 with lipid bilayers but a weaker interaction with the am-
yloid form of PAP248-286, as measured by the tendency of freshly dissolved
PAP248-286 to induce aggregation of lipid vesicles and membrane fusion. The
